Meningococcal vaccine groups A C Y W-135 polysaccharideLack of efficacy in meningococcus prevention: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2012年 / 1421卷 / 1期
关键词：
Meningitis; Ibuprofen; Ceftriaxone; Fresh Freeze Plasma; Disseminate Intravascular Coagulation;
D O I：
10.2165/00128415-201214210-00120
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：36 / 36
相关论文
共 50 条
  • [41] A Randomized Trial to Assess Safety and Immunogenicity of Alternative Formulations of a Quadrivalent Meningococcal (A, C, Y, and W-135) Tetanus Protein Conjugate Vaccine in Toddlers
    McVernon, Jodie
    Nolan, Terry
    Richmond, Peter
    Reynolds, Graham
    Nissen, Michael
    Lambert, Stephen B.
    Marshall, Helen
    Papa, Thomas
    Rehm, Christine
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (01) : E15 - E23
  • [42] Antibody responses to meningococcal (groups A, C, Y and W135) polysaccharide diphtheria toxoid conjugate vaccine in children who previously received meningococcal C conjugate vaccine
    El Bashir, H
    Heath, PT
    Papa, T
    Ruggeberg, JU
    Johnson, N
    Sinha, R
    Balfour, G
    Booy, R
    VACCINE, 2006, 24 (14) : 2544 - 2549
  • [43] The tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic with a clinically acceptable safety profile in subjects previously vaccinated with a tetravalent polysaccharide vaccine
    Dbaibo, Ghassan
    Van der Wielen, Marie
    Reda, Mariam
    Medlej, Fouad
    Tabet, Carelle
    Boutriau, Dominique
    Sumbul, Anne
    Anis, Sameh
    Miller, Jacqueline M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (08) : E608 - E615
  • [44] Persistence of antibodies for 42 months following vaccination of adolescents with a meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine (MenACWY-TT)
    Ostergaard, Lars
    Van der Wielen, Marie
    Bianco, Veronique
    Miller, Jacqueline M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (03) : E173 - E176
  • [45] Immunogenicity and Safety of a Multicomponent Meningococcal Serogroup B Vaccine and a Quadrivalent Meningococcal CRM197 Conjugate Vaccine against Serogroups A, C, W-135, and Y in Adults Who Are at Increased Risk for Occupational Exposure to Meningococcal Isolates
    Kimura, Alan
    Toneatto, Daniela
    Kleinschmidt, Annett
    Wang, Huajun
    Dull, Peter
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (03) : 483 - 486
  • [46] Acquisition of Meningococcal Serogroup W-135 Carriage in Turkish Hajj Pilgrims Who Had Received the Quadrivalent Meningococcal Polysaccharide Vaccine
    Ceyhan, M.
    Celik, M.
    Demir, E. T.
    Gurbuz, V.
    Aycan, A. E.
    Unal, S.
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (01) : 66 - 68
  • [47] Meningococcal Group W-135 and Y Capsular Polysaccharides Paradoxically Enhance Activation of the Alternative Pathway of Complement
    Ram, Sanjay
    Lewis, Lisa A.
    Agarwal, Sarika
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (10) : 8297 - 8307
  • [48] Meningococcal Quadrivalent (Serogroups A, C,W135, and Y) Conjugate Vaccine (Menveo®)In Adolescents and Adults
    Emma D. Deeks
    BioDrugs, 2010, 24 : 287 - 297
  • [49] Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)
    Jamie D. Croxtall
    Sohita Dhillon
    Drugs, 2012, 72 : 2407 - 2430
  • [50] Meningococcal Quadrivalent (Serogroups A, C, W135, and Y) Conjugate Vaccine (Menveo®) In Adolescents and Adults
    Deeks, Emma D.
    BIODRUGS, 2010, 24 (05) : 287 - 297
12345